» Articles » PMID: 35690832

The Immune Landscape of Solid Pediatric Tumors

Abstract

Background: Large immunogenomic analyses have demonstrated the prognostic role of the functional orientation of the tumor microenvironment in adult solid tumors, this variable has been poorly explored in the pediatric counterpart.

Methods: We performed a systematic analysis of public RNAseq data (TARGET) for five pediatric tumor types (408 patients): Wilms tumor (WLM), neuroblastoma (NBL), osteosarcoma (OS), clear cell sarcoma of the kidney (CCSK) and rhabdoid tumor of the kidney (RT). We assessed the performance of the Immunologic Constant of Rejection (ICR), which captures an active Th1/cytotoxic response. We also performed gene set enrichment analysis (ssGSEA) and clustered more than 100 well characterized immune traits to define immune subtypes and compared their outcome.

Results: A higher ICR score was associated with better survival in OS and high risk NBL without MYCN amplification but with poorer survival in WLM. Clustering of immune traits revealed the same five principal modules previously described in adult tumors (TCGA). These modules divided pediatric patients into six immune subtypes (S1-S6) with distinct survival outcomes. The S2 cluster showed the best overall survival, characterized by low enrichment of the wound healing signature, high Th1, and low Th2 infiltration, while the reverse was observed in S4. Upregulation of the WNT/Beta-catenin pathway was associated with unfavorable outcomes and decreased T-cell infiltration in OS.

Conclusions: We demonstrated that extracranial pediatric tumors could be classified according to their immune disposition, unveiling similarities with adults' tumors. Immunological parameters might be explored to refine diagnostic and prognostic biomarkers and to identify potential immune-responsive tumors.

Citing Articles

Enhanced immune responses are accompanied by increased MAGEA expression in osteosarcoma metastases.

Meijer D, van Oost S, Roelands J, Ruano D, Briaire-de Bruijn I, van den Akker B BMJ Oncol. 2025; 3(1):e000472.

PMID: 40046246 PMC: 11880787. DOI: 10.1136/bmjonc-2024-000472.


Prioritizing Context-Dependent Cancer Gene Signatures in Networks.

Capobianco E, Lisse T, Rieger S Cancers (Basel). 2025; 17(1.

PMID: 39796763 PMC: 11720092. DOI: 10.3390/cancers17010136.


Construction and clinical application of a risk model based on N6-methyladenosine regulators for colorectal cancer.

Zhu H, Yang Y, Zhou Z PeerJ. 2024; 12:e18719.

PMID: 39717046 PMC: 11665428. DOI: 10.7717/peerj.18719.


Recruitment and polarization typing of tumor-associated macrophages is associated with tumor progression and poor prognosis in Wilms tumor patients.

Wang Z, Jin L, Wang J, Tian X, Mi T, Li M PLoS One. 2024; 19(11):e0309910.

PMID: 39531417 PMC: 11556688. DOI: 10.1371/journal.pone.0309910.


Combining ERAP1 silencing and entinostat therapy to overcome resistance to cancer immunotherapy in neuroblastoma.

Tempora P, DAmico S, Gragera P, Damiani V, Krol K, Scaldaferri V J Exp Clin Cancer Res. 2024; 43(1):292.

PMID: 39438988 PMC: 11494811. DOI: 10.1186/s13046-024-03180-y.


References
1.
Snyder A, Makarov V, Merghoub T, Yuan J, Zaretsky J, Desrichard A . Genetic basis for clinical response to CTLA-4 blockade in melanoma. N Engl J Med. 2014; 371(23):2189-2199. PMC: 4315319. DOI: 10.1056/NEJMoa1406498. View

2.
Quintero Escobar M, Maschietto M, Krepischi A, Avramovic N, Tasic L . Insights into the Chemical Biology of Childhood Embryonal Solid Tumors by NMR-Based Metabolomics. Biomolecules. 2019; 9(12). PMC: 6995504. DOI: 10.3390/biom9120843. View

3.
Wolchok J . Checkpoint blockade: the end of the beginning. Nat Rev Immunol. 2021; 21(10):621. DOI: 10.1038/s41577-021-00617-9. View

4.
ONeill R, Du W, Mohammadpour H, Alqassim E, Qiu J, Chen G . T Cell-Derived CD70 Delivers an Immune Checkpoint Function in Inflammatory T Cell Responses. J Immunol. 2017; 199(10):3700-3710. PMC: 5687300. DOI: 10.4049/jimmunol.1700380. View

5.
Gu Z, Eils R, Schlesner M . Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics. 2016; 32(18):2847-9. DOI: 10.1093/bioinformatics/btw313. View